DCGI approves the country's first Nasal Vaccine for use..!?

India has won another victory against the Coronavirus. Country's first nasal vaccine approved for emergency use Union health minister Mansukh Mandaviya tweeted today that "Drugs Controller General of india (DCGI) has approved Bharat Biotech's Recombinant Covid-19 Nasal Vaccine. It is India's first nasal vaccine for the Covid-19 virus. Union health and Family Welfare minister Mansukh Mandaviya have expressed happiness over this. This is a huge boost in India's fight against the Corona epidemic! Bharat Biotech's ChAd36-SARS-CoV-S Covid-19 (chimpanzee adenovirus vector) recombinant nasal vaccine has been approved by the Central Medicines Quality Control System. Union health minister Mansukh Mandaviya said through a tweet that emergency use has been allowed for people above 18 years of age. In his next tweet, he said that this move further strengthens our collective efforts against the pandemic. He has said that india is making progress in the fight against Covid-19 under the leadership of prime minister Narendra Modi.

How does the nasal vaccine work?

A nasal spray vaccine is given through the nose. It builds immunity in the inner parts of the nose. It is considered very effective as the root of most airborne diseases, including corona, is mainly the nose. And building immunity in the inner parts of the nose is very effective in preventing such diseases.

Benefits of Nasal Vaccination:

Get relief from needles.
Health workers do not need training.
It is easy to administer this vaccine to children
As the cost is low, it can be delivered worldwide.

Nasal Vaccination - No Side Effects:

The Hyderabad-based company completed clinical trials of the nasal vaccine with around 4,000 volunteers. Company officials said there have been no side effects or adverse reactions so far.
For more interesting updates wa click and follow Indiaherald WhatsApp channel

Find out more:

first nasal vaccine in india

Sowmiya Sriram

06/09/2022 07:13 PM